Simon Jones

Professor Jones is a Professor in Musculoskeletal Ageing within the Institute of Inflammation and Ageing, University of Birmingham. He is an expert in the molecular mechanisms that mediate musculoskeletal ageing, including muscle loss with age (sarcopenia), ageing of the joint (osteoarthritis) and scoliosis (h-index=37; >5400 citations). Funded by bodies including UKRI, industry (AstraZeneca, Eli Lilly) and charities (Versus Arthritis, Dunhill Medical Trust), he has made sustained and significant contributions to the field. He has a particular research focus on the regulatory gene messages (called non-coding RNAs) and their central role in mediating inflammatory responses and in understanding how obesity affects the pathology of musculoskeletal tissues.
Previously, he was was a research leader in the pharmaceutical industry, leading small molecule projects in inflammation research (AstraZeneca, UK; 2003-2011), and development of new biological drugs (Boehringer Ingelheim, Vienna, Austria; 2011-2012).